Plain Text Law

Regulation .39 General Standards — Healthcare Facilities Managing Non-Creditable Hazardous Waste Pharmaceuticals.

Regulation .39 General Standards — Healthcare Facilities Managing Non-Creditable Hazardous Waste Pharmaceuticals.Copy Citation

A.
Training. The owner or operator of a healthcare facility managing non-creditable hazardous waste pharmaceuticals shall ensure that all personnel that manage non-creditable hazardous waste pharmaceuticals are thoroughly familiar with proper waste handling and emergency procedures relevant to their responsibilities during normal facility operations and emergencies.
B.
Hazardous Waste Determination.
(1)
A healthcare facility that generates a solid waste that is a non-creditable pharmaceutical shall determine whether that pharmaceutical is a hazardous waste pharmaceutical by determining whether the waste is listed as a hazardous waste in COMAR 26.13.02.15—.19, and whether the waste exhibits any of the characteristics of hazardous waste defined in COMAR 26.13.02.10—.14.
(2)
In determining whether a solid waste is a hazardous waste, a healthcare facility shall follow the procedures in COMAR 26.13.03.02-1.
(3)
A healthcare facility shall use the hazardous waste determination conducted in accordance with this section to determine the applicability of Regulations .32—.48 of this chapter to the waste, except that the healthcare facility may choose to manage its non-hazardous waste pharmaceuticals as non-creditable hazardous waste pharmaceuticals under Regulations .32—.48 of this chapter.
C.
Land Disposal Restrictions. A healthcare facility:
(1)
Shall ensure that the non-creditable hazardous waste pharmaceuticals generated by the facility are managed in accordance with the land disposal restrictions of 40 CFR Part 268, as incorporated by reference at COMAR 26.13.09.03A; and
D.
Response to Spills. A healthcare facility shall:
(1)
Immediately contain a spill of a non-creditable hazardous waste pharmaceutical; and
(2)
Manage spill cleanup materials as non-creditable hazardous waste pharmaceuticals in accordance with Regulations .32—.48 of this chapter.